الفهرس 
Prostate Cancer in the Arab World
Laparo-Endoscopic Single-Site Surgery:Only 14 pages are availabe for public view
 |  | from | 245 |  |  |
| | | from | 245 | | |
Abstract
According to the guideline, RP is the standard of care and is considered the treatment for fit patients with clinically localized PCa. The present study is the first one in literature to compare between the gold standard ORP and the novel RS-RARP surgical approaches for the treatment of clinically localized PCa. This prospective comparative study confers on the minimally invasive advantages of robotic surgery. Patients in the RS-RARP group have lower EBL, fewer blood transfusion rates, less postoperative pain, and shorter hospital stay compared to patients in the ORP group. The intraoperative and postoperative complications rates were comparable between ORP and RS-RARP groups. Regarding the early oncological outcomes, the PSM rate didn’t differ between ORP and RS-RARP surgical approaches. Similarly, the BCR and
BCRFS rates were similar with no statistically significant difference between ORP and RS-RARP groups. RS-RARP has significantly better early UC recovery than ORP in the first 6 months postoperatively. At 1-year follow up,urinary continence rate was 92% for patients in RS-RARP group and 84.7% for patients in ORP group. However, this difference was not statistically significant. In conclusion, Robotic surgery is a new promising surgery that confers less trauma and pain to the patients, more comfort to the surgeons,and as such should be encouraging to come to the horizon in the developing countries. The main difficulties include the high cost, lack of training and maintenance of supplies for robotic surgery. Further studies that overcome the limitations in the present study will be of more valuable in the future